Jasper Therapeutics Inc (JSPR)
Healthcare
Biotechnology
0.61 $
-3.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Jasper Therapeutics Inc (JSPR) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/03/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Submission of Matters to a Vote of Security Holders | View report → |
| 07/31/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Other Events | View report → |
| 07/17/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits | View report → |
| 07/16/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Regulation FD Disclosure; Financial Statements and Exhibits | View report → |
Showing the 100 most recent filings of the selected type.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.